The Malaysian health care system has long been hailed as a beacon of progress and accessibility. However, a dark cloud has been looming over this once revered institution, casting a shadow of doubt and disillusionment among the very providers tasked with safeguarding the nation’s well-being.
At the centre of this maelstrom lies the Ministry of Health (MOH), an entity that has seemingly abandoned its core mandate of ensuring equitable and transparent health care policies.
Instead, it has become a playground for the powerful, catering to the whims and interests of a select few, while the hardworking private health care providers are left to bear the brunt of its unfair one-sided decisions.
The MOH’s actions, or rather, its inactions, have become a source of growing frustration and resentment among private sector practitioners. Time and again, these dedicated professionals have witnessed the encroachment of their domain by the very entities they are meant to collaborate with, the insurers, managed care organisations (MCOs), third-party administrators (TPAs), and pharmaceutical
conglomerates.
These powerful players, often shielded by the MOH’s tacit approval, have carved out a niche for themselves, operating as parasites within the health care ecosystem.
They have systematically eroded the autonomy and decision-making power of the private practitioners, dictating treatment protocols, pricing, and even the very essence of the doctor-patient relationship.
The root of this malaise can be traced directly to the doorstep of the MOH and its top echelons whose apparent allegiance to these vested interests has become a source of deep concern.
Its unwavering support for these entities, coupled with the blatant disregard for the plight of private health care providers, has left many questioning the integrity and transparency of the MOH’s policies.
The MOH cites the ridiculous claim by blaming the price discrepancy of drugs that general practitioners dispense as the sole reason for undue hardships to people.
While the actual culprit here is the MOH when they fail in their duties to procure lifesaving vaccines and medicines on time, thus compromising the safety of patients under the care of doctors in hospitals and in private health care.
Why are the tender bids not transparent and shockingly why is their official e-portal closed. It’s even more appalling when MOH sources generic medications at 100 to 150 per cent of the original price and that too from local manufacturers.
The consequences of these imbalances are far reaching, with patients bearing the brunt of the burden. Reduced access to quality care, escalating costs, and a growing sense of mistrust in the health care system have become the hallmarks of this troubling trend.
As the nation grapples with the challenges of a post-pandemic world, the need for a robust and equitable health care system has never been more pressing. It is time for the MOH to heed the cries of private health care providers and recalibrate its priorities, placing the well-being of the people above the interests of the powerful few and their vested interests.
Only then can the promise of a truly accessible and compassionate health care system be realised, restoring the trust and confidence that the people of Malaysia so rightfully deserve.
This statement was issued by Dr Devadas Pathiyil Ramankutty, president of the Association of Private Practitioners Sabah (APPS).
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.
